SYMETRYX CORP purchased 9.9% of their position (61.08K shares) of NEUBASE THERAPEUTICS, INC. on the open market
Open‑market purchase worth $59.7K — a moderate purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 9/7/2023ACC: 0001991925-23-000002
+61.08K
Net shares
Net buyer
$59.7K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
61.08K acquired
Non-Derivative Transactions1
Common Stock, Par Value $0.0001 per Share
Direct
Shares
+61.08K
Price / share
$0.98
Trade value
$59.73K
% of position
9.9%
9/1/2023
619K→680.08K
Total
Net shares
+61.08K
Net value
$59.73K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.0001 per Share Direct | 9/1/2023 | P · Purchase | +61.08K | $0.98 | $59.73K | 9.9% | 619K | 680.08K |
| Total | +61.08K | $59.73K | ||||||
Derivative Transactions0
No derivative transactions reported